UNITED THERAPEUTICS Corp - 10-Q Filing

United Therapeutics Corp reports third quarter 2026 financial results and updates on credit facilities and equity incentive plans.

SEC EDGAR ·

Tickers: $UTHR

Read the full article at SEC EDGAR

More Regulatory news